Global Medical REIT (NYSE: GMRE) is one of 23 publicly-traded companies in the “Healthcare REITs” industry, but how does it contrast to its competitors? We will compare Global Medical REIT to similar businesses based on the strength of its risk, profitability, analyst recommendations, institutional ownership, valuation, dividends and earnings.

Earnings & Valuation

This table compares Global Medical REIT and its competitors revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Global Medical REIT $8.21 million -$6.35 million -30.56
Global Medical REIT Competitors $812.10 million $208.81 million 125.13

Global Medical REIT’s competitors have higher revenue and earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

41.0% of Global Medical REIT shares are owned by institutional investors. Comparatively, 83.1% of shares of all “Healthcare REITs” companies are owned by institutional investors. 16.5% of Global Medical REIT shares are owned by insiders. Comparatively, 6.2% of shares of all “Healthcare REITs” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk and Volatility

Global Medical REIT has a beta of -0.18, indicating that its share price is 118% less volatile than the S&P 500. Comparatively, Global Medical REIT’s competitors have a beta of 0.43, indicating that their average share price is 57% less volatile than the S&P 500.

Dividends

Global Medical REIT pays an annual dividend of $0.80 per share and has a dividend yield of 9.7%. Global Medical REIT pays out -296.3% of its earnings in the form of a dividend. As a group, “Healthcare REITs” companies pay a dividend yield of 5.4% and pay out 133.5% of their earnings in the form of a dividend. Global Medical REIT is clearly a better dividend stock than its competitors, given its higher yield and lower payout ratio.

Analyst Recommendations

This is a summary of recent ratings and price targets for Global Medical REIT and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Medical REIT 0 1 5 0 2.83
Global Medical REIT Competitors 142 757 681 12 2.35

Global Medical REIT presently has a consensus price target of $10.75, suggesting a potential upside of 30.30%. As a group, “Healthcare REITs” companies have a potential upside of 5.10%. Given Global Medical REIT’s stronger consensus rating and higher probable upside, research analysts clearly believe Global Medical REIT is more favorable than its competitors.

Profitability

This table compares Global Medical REIT and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Global Medical REIT -19.98% -2.86% -1.39%
Global Medical REIT Competitors 35.60% 7.69% 3.77%

Summary

Global Medical REIT competitors beat Global Medical REIT on 9 of the 15 factors compared.

About Global Medical REIT

Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, purpose-built healthcare facilities and the leasing of these facilities to clinical operators with market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market operators under long-term triple-net leases.

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.